Panel: How Biotechs are Leveraging AI/ML to Drive Efficiency and ROI

Session details:

AI-native biotechs are showing the industry that machine learning isn’t just for discovery — it’s an engine for speed, efficiency, and smarter development across the pipeline. This panel brings together pioneering leaders to share how they’re using generative models, wet lab integration, and large language models (LLMs) to accelerate drug development, improve clinical success, and maximize return on investment. From faster capsid design and de novo protein generation to AI-enhanced clinical prediction, hear the lessons, challenges, and real-world wins shaping biotech’s AI future.

• Leveraging AI/ML for faster target ID, molecule design, and validation
• Integrating AI with wet lab systems for faster validation cycles
• Improving clinical trial efficiency and patient selection
• Where companies are seeing real ROI and where the hype hasn’t delivered
• How biotech leaders measure ROI on AI investments